Neurogene (NGNE) Market Capitalization (2014 - 2026)
Neurogene (NGNE) recorded Market Capitalization of $709.26 million in Q2 2026, up 125.3% from $314.78 million a year earlier and up 57.7% from the prior quarter.
Powered by 
Analysis
Neurogene (NGNE) Market Capitalization (2014 - 2026) Analysis & Trends
For FY2025, Neurogene reported Market Capitalization of $439.32 million, up 29.4% from FY2024.
- Annual Market Capitalization has a five-year compound annual growth rate of -5.9% (FY2020 to FY2025).
- Across earlier years, Market Capitalization came in at $339.58 million in FY2024, $9.53 million in FY2023 (-66.1%), $28.11 million in FY2022 (-89.4%) and $265.3 million in FY2021 (-55.4%).
- The Q2 2026 figure is the highest quarterly Market Capitalization since Q3 2024.
- On a year-over-year basis, Market Capitalization has increased for three consecutive quarters, with growth averaging 11.5% over the last six quarters.
- Peak year-over-year performance for Market Capitalization in the last five years was growth of 125.3% in Q2 2026, against a decline of 91.1% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $449.68 million (Q1 2026), $439.32 million (Q4 2025) and $366.85 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Neurogene | 586.35 Mn | -416.64 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 709.26 Mn |
| Mar 31, 2026 | 449.68 Mn |
| Dec 31, 2025 | 439.32 Mn |
| Sep 30, 2025 | 366.85 Mn |
| Jun 30, 2025 | 314.78 Mn |
| Mar 31, 2025 | 245.87 Mn |
| Dec 31, 2024 | 339.58 Mn |
| Sep 30, 2024 | 711.37 Mn |
| Jun 30, 2024 | 616.50 Mn |
| Mar 31, 2024 | 860.40 Mn |
| Dec 31, 2023 | 9.53 Mn |
| Sep 30, 2023 | 43.85 Mn |
| Jun 30, 2023 | 46.61 Mn |
| Mar 31, 2023 | 38.79 Mn |
| Dec 31, 2022 | 28.11 Mn |
| Sep 30, 2022 | 35.36 Mn |
| Jun 30, 2022 | 56.86 Mn |
| Mar 31, 2022 | 103.67 Mn |
| Dec 31, 2021 | 265.30 Mn |
| Sep 30, 2021 | 398.28 Mn |
API Access
Neurogene Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=NGNE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "NGNE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=NGNE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();